[Multiple endocrine neoplasia]

Area of Science:

• Endocrinology
• Genetics
• Oncology

Background:

• Multiple endocrine neoplasia (MEN) types 1 and 2 are inherited cancer syndromes.
• MEN1 is associated with parathyroid, pituitary, and pancreas tumors, driven by MEN1 gene mutations.
• MEN2 involves medullary thyroid carcinoma, pheochromocytoma, and parathyroid tumors, linked to RET gene mutations.

Purpose of the Study:

• To summarize the genetic basis and clinical manifestations of MEN1 and MEN2.
• To highlight the importance of genotype-phenotype correlations, particularly in MEN2.
• To emphasize the benefits of early diagnosis and therapeutic interventions.

Main Methods:

• Review of genetic mutations in MEN1 (tumor suppressor) and MEN2 (oncogene).
• Analysis of clinical presentations and tumor types associated with each MEN type.
• Evaluation of screening protocols and treatment outcomes.

Main Results:

• MEN1 and MEN2 are autosomal dominant disorders with distinct tumor profiles.
• A strong genotype-phenotype correlation exists in MEN2, aiding prediction.
• Biochemical and imaging screening facilitate early detection.
• Early thyroidectomy in MEN2 patients leads to high cure rates for medullary thyroid carcinoma.

Conclusions:

• MEN1 and MEN2 are distinct hereditary cancer syndromes with identifiable genetic causes.
• Personalized screening and early intervention strategies are crucial for managing these conditions.
• Proactive management, including prophylactic thyroidectomy in MEN2, offers favorable prognoses.